Pnet, South Africa’s leading online recruitment platform, has released its Pnet Job Market Trends Report, including the 2026 Salary Guide. This essential analysis offers salary ranges for more than ...

Pnet has released its Job Market Trends Report for January 2026, which highlights average salary ranges for various jobs in South Africa. The firm’s 2026 Salary Guide features up-to-date salary ...

Online recruitment firm Pnet has published its 2026 Job Market Trends Report, which includes salary guides and ranges for various jobs in South Africa. The group’s analysis covers salary ranges for ...

Pnet, South Africa’s leading online recruitment platform, has released its Job Market Trends Report for December 2025, including the Pnet Job Guide for the year ahead. The analysis highlights fierce ...

South African online recruitment platform, Pnet, has revealed which jobs are most in-demand in the country based on data gathered in December 2025. The platform’s analysis includes not only jobs in ...

Tech hiring has rebounded in South Africa in recent months, according to Pnet data. This follows a long period of decline, driven in part by layoffs at big tech companies. There has also been a ...

PNETs are classified as functional or non-functional, influencing symptoms and treatment strategies. Tumor grade impacts prognosis and treatment plans. Diagnosis involves imaging, blood tests, and ...

Soon to be the official tool for managing Python installations on Windows, the new Python Installation Manager picks up where the ‘py’ launcher left off. Python is a first-class citizen on Microsoft ...

A startling milestone has been reached in Florida's war against the invasive Burmese pythons eating their way across the Everglades. The Conservancy of Southwest Florida reports it has captured and ...

10-year follow up of a phase 2 clinical trial of pembrolizumab (pembro) in microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) advanced solid tumors. This is an ASCO Meeting ...

The US Food and Drug Administration (FDA) has approved cabozantinib (Cabometyx, Exelixis, Inc.) for certain adults and children aged ≥ 12 years with previously treated, well-differentiated pancreatic ...